More Cambium Bio Ltd news
Cambium Bio LtdASX: CMB

Regeneus and Kyocera sign Progenza OA deal

Aug 11, 2020 at 12:12 AM EDT · Issued by Cambium Bio Ltd

Filed with ASX · Aug 11, 2020 at 12:12 AM EDT · 4 pages · English

On 6ix: 6ix.com/news/regeneus-and-kyocera-sign-progenza-oa-deal

Cambium Bio Ltd on 6ix

Story so far

  • Progenza OA Kyocera negotiations updateJul 28, 2020
  • Kyocera completes Progenza Due DiligenceMay 18, 2020
  • Regeneus receives A$1.6M milestone payment from KyoceraMar 20, 2020

Earlier from Cambium Bio

  • Progenza OA Kyocera negotiations updateJul 27, 2020
  • Kyocera completes Progenza Due DiligenceMay 17, 2020
  • Appendix 4C UpdatedMay 5, 2020
  • Regeneus to be granted new key Progenza patent in U.S.Mar 22, 2020
  • Regeneus receives A$1.6M milestone payment from KyoceraMar 19, 2020

Later from Cambium Bio

  • US Patent for SygenusAug 18, 2020
  • Regeneus to present at FNN Virtual Investor EventAug 25, 2020
  • Appendix 4E and Annual ReportAug 28, 2020
  • Regeneus receives milestone payment from KyoceraAug 28, 2020
  • Regeneus to be granted new Sygenus patent in CanadaOct 6, 2020
All Cambium Bio news releases↗

Follow Cambium Bio into a list and get an email when it puts out news.

Follow Cambium Bio
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer